Free Trial
NYSE:WAT

Waters (WAT) Stock Price, News & Analysis

Waters logo
$413.63 +9.63 (+2.38%)
As of 01/21/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Waters Stock (NYSE:WAT)

Key Stats

Today's Range
$402.22
$416.24
50-Day Range
$344.80
$413.63
52-Week Range
$279.24
$416.24
Volume
670,147 shs
Average Volume
473,821 shs
Market Capitalization
$24.56 billion
P/E Ratio
39.47
Dividend Yield
N/A
Price Target
$384.71
Consensus Rating
Hold

Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Waters Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
88th Percentile Overall Score

WAT MarketRank™: 

Waters scored higher than 88% of companies evaluated by MarketBeat, and ranked 132nd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Waters has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 4 buy ratings, 9 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Waters has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Waters' stock forecast and price target.
  • Earnings Growth

    Earnings for Waters are expected to grow by 9.16% in the coming year, from $11.79 to $12.87 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Waters is 39.47, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.77.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Waters is 39.47, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 88.83.

  • Price to Earnings Growth Ratio

    Waters has a PEG Ratio of 7.07. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Waters has a P/B Ratio of 21.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Waters' valuation and earnings.
  • Percentage of Shares Shorted

    3.12% of the float of Waters has been sold short.
  • Short Interest Ratio / Days to Cover

    Waters has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Waters has recently decreased by 6.57%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Waters does not currently pay a dividend.

  • Dividend Growth

    Waters does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.12% of the float of Waters has been sold short.
  • Short Interest Ratio / Days to Cover

    Waters has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Waters has recently decreased by 6.57%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Waters has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 36 news articles for Waters this week, compared to 32 articles on an average week.
  • Search Interest

    4 people have searched for WAT on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Waters to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Waters insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.82% of the stock of Waters is held by insiders.

  • Percentage Held by Institutions

    94.01% of the stock of Waters is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Waters' insider trading history.
Receive WAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

WAT Stock News Headlines

Trump’s Inauguration Shocker: “Move Your Cash Now”
Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's issuing this NEW warning about Trump's inauguration.
See More Headlines

WAT Stock Analysis - Frequently Asked Questions

Waters' stock was trading at $370.98 at the beginning of 2025. Since then, WAT shares have increased by 11.5% and is now trading at $413.6270.
View the best growth stocks for 2025 here
.

Waters Co. (NYSE:WAT) released its earnings results on Friday, November, 1st. The medical instruments supplier reported $2.93 earnings per share for the quarter, topping analysts' consensus estimates of $2.68 by $0.25. The firm's quarterly revenue was up 4.0% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Waters: Andrew Alliance S.A, Andrew Alliance, Rubotherm, MPE Orbur Group Ltd. (UK), ElectroForce, Blue Reference Inc., Baehr Thermoanalyse GmbH, and more.

Waters' top institutional shareholders include Fenimore Asset Management Inc (0.39%), Nordea Investment Management AB (0.30%), Nisa Investment Advisors LLC (0.05%) and Assenagon Asset Management S.A. (0.05%). Insiders that own company stock include Edward Conard, Christopher A Kuebler, Mark P Vergnano, Linda Baddour and Richard H Fearon.
View institutional ownership trends
.

Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Waters investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
11/01/2024
Today
1/21/2025
Next Earnings (Estimated)
2/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
94184810
Employees
7,900
Year Founded
1958

Price Target and Rating

Average Stock Price Target
$384.71
High Stock Price Target
$430.00
Low Stock Price Target
$312.00
Potential Upside/Downside
-7.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
15 Analysts

Profitability

Net Income
$642.23 million
Pretax Margin
24.63%

Debt

Sales & Book Value

Annual Sales
$2.96 billion
Cash Flow
$14.93 per share
Book Value
$19.45 per share

Miscellaneous

Free Float
58,889,000
Market Cap
$24.56 billion
Optionable
Optionable
Beta
1.01

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (NYSE:WAT) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners